What is the Fiscal Year for Beta Bionics?
Date: November 13, 2026
Beta Bionics's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Irvine, CA
Industry
Biotechnology
Stock Symbol
BBNX
Website
http://www.betabionics.comDescription
Headquartered in Irvine, California, Beta Bionics, Inc. is redefining what’s possible in diabetes care. By listening to people living with diabetes, their families, and their care teams, the company created the iLet Bionic Pancreas – the only automated insulin delivery system with a fully closed loop algorithm that adapts to each person. The iLet determines and delivers every insulin dose, reducing the daily burden on users. With this innovative approach, Beta Bionics is focused on bringing greater ease, confidence, and freedom to people managing diabetes every day. For safety information, visit: www.betabionics.com/safety.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Beta Bionics and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.